In vivo modulation of vaccine-induced immune responses toward a Th1 phenotype increases potency and vaccine effectiveness in a herpes simplex virus type 2 mouse model.
about
Increased Immunogenicity of a DNA-Launched Venezuelan Equine Encephalitis Virus-Based Replicon DNA VaccineLiposomal gD ectodomain (gD1-306) vaccine protects against HSV2 genital or rectal infection of female and male mice.Recombinant herpes simplex virus type 1 (HSV-1) codelivering interleukin-12p35 as a molecular adjuvant enhances the protective immune response against ocular HSV-1 challengeModulation of antigen-specific humoral responses in rhesus macaques by using cytokine cDNAs as DNA vaccine adjuvantsDNA vaccines encoding interleukin-8 and RANTES enhance antigen-specific Th1-type CD4(+) T-cell-mediated protective immunity against herpes simplex virus type 2 in vivoModulation of immunity against herpes simplex virus infection via mucosal genetic transfer of plasmid DNA encoding chemokines.Recent progress in herpes simplex virus immunobiology and vaccine researchInterleukin 7 can enhance antigen-specific cytotoxic-T-lymphocyte and/or Th2-type immune responses in vivo.Recombinant vesicular stomatitis virus vectors expressing herpes simplex virus type 2 gD elicit robust CD4+ Th1 immune responses and are protective in mouse and guinea pig models of vaginal challenge.Comparison of adjuvant efficacy of herpes simplex virus type 1 recombinant viruses expressing TH1 and TH2 cytokine genes.Combined stimulation of IL-2 and 4-1BB receptors augments the antitumor activity of E7 DNA vaccines by increasing Ag-specific CTL responses.Quantification of poly(I:C)-mediated protection against genital herpes simplex virus type 2 infection.Local and systemic effect of transfection-reagent formulated DNA vectors on equine melanoma.DNA vaccines against human immunodeficiency virus type 1 in the past decade.Induction of specific immune responses by severe acute respiratory syndrome coronavirus spike DNA vaccine with or without interleukin-2 immunization using different vaccination routes in mice.Estradiol Enhances CD4+ T-Cell Anti-Viral Immunity by Priming Vaginal DCs to Induce Th17 Responses via an IL-1-Dependent PathwayProphylactic vaccine strategies and the potential of therapeutic vaccines against herpes simplex virusGenetic immunization with Hantavirus vaccine combining expression of G2 glycoprotein and fused interleukin-2Cholera toxin B subunit acts as a potent systemic adjuvant for HIV-1 DNA vaccination intramuscularly in mice.Adjuvant activities of novel cytokines, interleukin-23 (IL-23) and IL-27, for induction of hepatitis C virus-specific cytotoxic T lymphocytes in HLA-A*0201 transgenic mice.Enhanced potency of replicon vaccine using one vector to simultaneously co-express antigen and interleukin-4 molecular adjuvant.Feline leukemia virus DNA vaccine efficacy is enhanced by coadministration with interleukin-12 (IL-12) and IL-18 expression vectors.Protective antiviral immune responses to pseudorabies virus induced by DNA vaccination using dimethyldioctadecylammonium bromide as an adjuvant.Suppression of antitumour protective cytotoxic T lymphocyte responses to a human papillomavirus 16 E7 DNA vaccine by coinjection of interleukin-12 complementary DNA: involvement of nitric oxide in immune suppression.Local and systemic effect of transfection-reagent formulated DNA vectors on equine melanoma.Immunogenicity of a bovine herpesvirus 1 glycoprotein D DNA vaccine complexed with bovine neutrophil beta-defensin 3T helper 1-type cytokine transcription in peripheral blood mononuclear cells of pseudorabies virus (Suid herpesvirus 1)-primed swine indicates efficient immunization.Both antigen optimization and lysosomal targeting are required for enhanced anti-tumour protective immunity in a human papillomavirus E7-expressing animal tumour model.US6 Gene Deletion in Herpes Simplex Virus Type 2 Enhances Dendritic Cell Function and T Cell Activation.Immunity to vaginal herpes simplex virus-2 infection in B-cell knockout mice.An M2 Rather than a TH2 Response Contributes to Better Protection against Latency Reactivation following Ocular Infection of Naive Mice with a Recombinant Herpes Simplex Virus 1 Expressing Murine Interleukin-4.Antiviral protection after DNA vaccination is short lived and not enhanced by CpG DNA
P2860
Q27485003-91F57E1E-312E-4D3B-AA3A-7F9F693BDF20Q33668447-20DB9BDC-BB64-482A-96D6-2F00CD7A04FEQ33737614-80DE44AC-E0EB-4F23-8180-6A01A3BB0C88Q33801810-F959B8DF-F1FB-43E2-9202-128E462AFCDAQ33827001-9C5BA907-A059-41DE-995B-46F6EA7AAA7EQ33835204-AE801EEC-B879-44B6-92FD-E9ECC7F9B5E7Q33963713-AE381457-ED33-4CF2-A417-2E8EC27F2F4BQ33998592-9CDFD13A-E7AB-4588-8AFB-D177310AA149Q34647625-BFC431F6-D3EA-4DEA-BFE5-E55C3965D5DFQ34976868-002E28FC-1182-4109-A875-A6B55E3CE1C4Q35082617-F75B22A3-581E-477B-8C51-1CDA7330D5FCQ35101552-B2AF202B-3187-44A1-9D0D-FCC34BD35108Q35600772-9D176A3E-C54C-450C-9CBD-65BE07FD2ACCQ35745831-65B50ED9-3D51-44F2-8CED-001AF38EAF38Q35946863-66BD799B-56A8-468B-A4C4-86E11B296E3FQ36009231-466BA366-85F9-4EC5-BCA1-4CC2E004D842Q36879345-A62F12E3-CACF-4AB5-BD1E-A70C429DDFFAQ36958845-5B96B44D-D2E5-431F-8B88-92771A882064Q36977797-FD5E8B47-15A5-4B92-9FEE-4DA6DFD59F3BQ37349027-0AB0CB79-0A61-40C7-81F9-CBC402B03177Q37384713-F7ABE351-2F92-4D17-8787-97A45F25FE6EQ39606955-101FB1AF-9757-4281-8F2F-84E34651219BQ39684976-171454D9-94BC-47CF-9ED1-3A8C05B91EECQ39796159-2C6CC432-D318-41FC-A7D2-7FFF6AE452FFQ41679793-1BF1C886-E24D-421A-A0D7-47888500C7B5Q42181972-5253BBC1-577F-46C5-B3A7-BD8ECD783EA0Q43687994-81536820-4ED5-4AD8-B7CC-23E669527D9DQ43854654-E1E5BEB9-5A1D-4976-B272-A219692DD3D1Q45324219-2A68995F-4E14-4F1D-83A0-AE8EECA65340Q45740405-C8E941F6-33D4-4D0E-9713-A4B18A38EF68Q54264680-3F32DB0F-F7A6-4025-8B6E-D2A33070938BQ58608760-8BCBEFEA-99A6-48A9-9CFA-0C613D61A1C4
P2860
In vivo modulation of vaccine-induced immune responses toward a Th1 phenotype increases potency and vaccine effectiveness in a herpes simplex virus type 2 mouse model.
description
1999 nî lūn-bûn
@nan
1999 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
In vivo modulation of vaccine- ...... plex virus type 2 mouse model.
@ast
In vivo modulation of vaccine- ...... plex virus type 2 mouse model.
@en
type
label
In vivo modulation of vaccine- ...... plex virus type 2 mouse model.
@ast
In vivo modulation of vaccine- ...... plex virus type 2 mouse model.
@en
prefLabel
In vivo modulation of vaccine- ...... plex virus type 2 mouse model.
@ast
In vivo modulation of vaccine- ...... plex virus type 2 mouse model.
@en
P2093
P2860
P1433
P1476
In vivo modulation of vaccine- ...... mplex virus type 2 mouse model
@en
P2093
P2860
P304
P577
1999-01-01T00:00:00Z